Priority Urgent Care

Priority Urgent Care was paid $14.89M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.

33Billing provider infoPRIORITY URGENT CARE
BAKERSFIELD, CA 93313

33aNPI1881148096assigned 08/05/2016

33bProvider typeUrgent Care Clinic/Center

28Total paid$14.89M

24GClaims260,189

24DCodes billed56

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Urgent Care Clinic/Center providers in California

Rank by total paid#13 of 284

Median peer was paid$147K

This provider vs. median101×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	22,212	$1.29M
2019	20,230	$1.13M
2020	25,787	$1.53M
2021	41,736	$2.06M
2022	54,085	$2.83M
2023	55,524	$2.75M
2024incomplete	40,615	$3.30M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	59%	102,272	98,861	$8.84M
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	25%	42,902	42,806	$3.72M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	7.9%	13,528	13,023	$1.17M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.7%	6,379	6,367	$555K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.1%	6,389	6,274	$464K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	18,747	18,434	$28K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	13,268	12,767	$23K
87428		<1%	8,810	8,735	$18K
81002		<1%	13,967	13,748	$11K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	77	76	$11K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	116	116	$10K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	127	127	$7K

44 more codes

87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,445	$4K
99205	Prolong outpt/office vis	<1%	29	$4K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,608	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,068	$4K
71046	Radiologic examination, chest; 2 views	<1%	2,093	$3K
93000		<1%	441	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,816	$2K
81025		<1%	5,853	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	903	$1K
99000		<1%	833	$953.27
98966		<1%	20	$735.00
72110		<1%	54	$305.23
73610		<1%	226	$298.11
73130		<1%	228	$280.14
99070		<1%	543	$255.00
87430		<1%	598	$255.00
10060		<1%	27	$211.09
73630		<1%	156	$184.17
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	209	$170.14
73110		<1%	42	$170.00
82948		<1%	72	$170.00
36415	Collection of venous blood by venipuncture	<1%	626	$170.00
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	<1%	73	$85.00
73562		<1%	37	$85.00
73030		<1%	12	$51.20
73620		<1%	12	$40.00
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	6,582	$37.70
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	33	$18.77
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	97	$17.56
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	197	$0.09
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	0%	190	$0.00
90714		0%	16	$0.00
S0077	Injection, clindamycin phosphate, 300 mg	0%	17	$0.00
99173		0%	24	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	13	$0.00
A6451	Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard	0%	20	$0.00
72100		0%	12	$0.00
99051		0%	16	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	162	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	44	$0.00
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	38	$0.00
A6449	Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard	0%	30	$0.00
A9150	Non-prescription drugs	0%	44	$0.00
A6448	Light compression bandage, elastic, knitted/woven, width less than three inches, per yard	0%	48	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLOEWEN, MARK (OWNER)